Amaran Biotech is pleased to announce our participation in the 7th Vaccine World Asia Congress 2025 – South East Asia, where we will introduce our proprietary AB-801(QS-21) vaccine adjuvant and share insights into how it accelerates vaccine commercialization.
Presentation Details:
- Date: November 5, 2025 (Wednesday)
- Time: 9:30 AM
- Venue: Amari Bangkok, Thailand
- Topic: Building the Future on a Solid Foundation: How Superior Adjuvants AB-801 Accelerate Vaccine Commercialization
- Speaker: William Feng, Head of Adjuvant, Amaran Biotech
Join us at this premier regional vaccine event to explore how Amaran Biotech addresses the QS-21 paradox and empowers partners with superior adjuvant technology for next-generation vaccine development.
🔗 Event Website: Vaccine World Asia Congress 2025 – South East Asia